Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment.
Bui TO, Angeli E, El Bouchtaoui M, Gapihan G, Dao VT, Paris J, Leboeuf C, Soussan M, Villarese P, Ziol M, Van Glabeke E, Le TH, Feugeas JP, Janin A, Bousquet G.
Bui TO, et al. Among authors: dao vt.
Exp Hematol Oncol. 2023 May 15;12(1):46. doi: 10.1186/s40164-023-00408-z.
Exp Hematol Oncol. 2023.
PMID: 37189165
Free PMC article.